Redeye initiates coverage of Serstech, a rapidly growing player in the niche market for handheld Raman spectrometers. Its devices can pinpoint more than 17,000 hazardous substances directly on the field, offering an attractive proposition for border control services, narcotics police, and military organisations. Thanks to c268% sales growth and positive net income during 2023, Serstech is establishing itself as a potent threat to the current, slow-moving market leaders.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Serstech - Identifying an emerging niche market leader

© Modular Finance, source Nordic Press Releases